Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

ClinicalTrials.gov ID: NCT06908226

Public ClinicalTrials.gov record NCT06908226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label Study to Investigate the Long-Term Safety and Efficacy of LP352 in the Treatment of Seizures in Children and Adults With Developmental and Epileptic Encephalopathy

Study identification

NCT ID
NCT06908226
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Longboard Pharmaceuticals
Industry
Enrollment
324 participants

Conditions and interventions

Interventions

  • LP352 Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 66 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 11, 2025
Primary completion
Nov 10, 2027
Completion
Dec 16, 2027
Last update posted
Jul 16, 2026

2025 – 2027

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
18
Facility City State ZIP Site status
Arkansas Children's Hospital - PIN Little Rock Arkansas 72202-3500
David Geffen School of Medicine at UCLA Los Angeles California 90095-3075
The Stanford Division of Child Neurology Palo Alto California 94304-1510
UCSF Children's Hospital San Francisco California 94143-2350
Childrens Hospital Colorado - PIN Aurora Colorado 80045-7106
NW FL Clinical Research Group, LLC Gulf Breeze Florida 32561-4458
University of Miami - 1120 NW 14th St Miami Florida 33136-2107
Research Institute of Orlando LLC Orlando Florida 32806-5411
University of South Florida - 2 Tampa General Circle Tampa Florida 33606
Pediatric Epilepsy and Neurology Specialists Tampa Florida 33609-4181
Consultants In Epilepsy and Neurology PLLC Boise Idaho 83702-5029
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817-1809
Massachusetts General Hospital Boston Massachusetts 02114-2621
Mayo Clinic - PIN Rochester Minnesota 55905-0001
Institute of Neurology and Neurosurgery at Saint Barnabas, LLC Livingston New Jersey 07039-5817
Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave Morristown New Jersey 07960
NYU Comprehensive Epilepsy Center - BRANY - PPDS New York New York 10016-4852
Child Neurology Consultants of Austin - 6811 Austin Center Blvd Austin Texas 78731-3157
The University of Texas Medical School at Houston Houston Texas 77030-3000

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06908226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06908226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →